A JAMA Network Surgery study tracks the shift, but Tulane surgeon Shauna Levy says Louisiana insurers cover surgery more often than GLP-1s.
Recap by typeshit. Full story at KKTV.
U of T researchers built the AI tool with the aim of speeding up how new peptide drugs are found. The university's announcement has the details.
Fractyl plans to file a De Novo request with the FDA in late Q4, yet its shares closed about 63% lower that day over a class action and doubts about 12-month results.
Health records from 131 million adults linked GLP-1s to fewer dialysis or transplant cases. The researchers stress the study is observational and can't prove cause.
Centre Daily Times looks at how peptides taken by mouth can get past the gut intact and reach specific spots in the body, a key hurdle for pill versions of these drugs.
A JAMA Network Surgery study found GLP-1 prescriptions up 24% since 2018, while a Tulane surgeon says Louisiana insurance favors surgery.
A JAMA Network Surgery study found GLP-1 prescriptions up 24% since 2018. A Tulane surgeon says in Louisiana, surgery is more often covered than the drugs.
Loading…